Avaliação do efeito do Mycobacterium bovis BCG sobre a resposta imunológica em modelo murino de alergia pulmonar
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
Atopic asthma is a chronic respiratory disease characterized by airway
hyperresponsiveness, reversible airway obstruction, lung inflammation, and high
levels of allergen-specific IgE, driven by allergen-specific Th2 cells. The increasing
prevalence of allergic diseases, particularly in industrialized countries, has led to the
hygiene hypothesis, which states that the newborn infant’s immune system is
skewed toward Th2 responses and needs timely and appropriate environmental
stimulus to create a balanced immune response. Supporting this hypothesis,
epidemiological and experimental evidence has shown an inverse correlation
between Th1-induced microbial infections and atopic asthma. Similarly, some
animal studies have demonstrated that exposure to Mycobacterium tuberculosis or
to environmental mycobacteria is able to protect against the development of allergic
responses. However the exact mechanism underlying this inhibition still remains
poorly understood. This study aimed to evaluate the ability of BCG to suppress an
established allergic response in a mouse model of OVA-induced airway
inflammation. To achieve this, OVA sensitized and challenged BALB/c mice were
twice treated with BCG via nasal and 21 days after the first treatment, mice were rechallenged
with OVA. Twenty-four hours after the last challenge, blood samples
were collected to detect anti-OVA immunoglobulin isotypes, and bronchoalveolar
lavage (BAL) was harvested for cell count. Additionally, lungs were collected for
histological analysis, detection of EPO activity and measurement of cytokines and
chemokines. The expression of CTLA-4, Foxp3 and IL-10 was also determined in
lung tissue by flow cytometry. The data indicated that BCG treatment was able to
inhibit an established allergic Th2-response by decreasing the allergen-induced
eosinophilic inflammation, EPO activity, levels of IL-4, IL-13, CCL11 and serum
levels of IgE and IgG1. Mycobacteria treatment increased lung levels of IFN-γ, IL-10
and TGF-β, and expressions of Foxp3 and CTLA-4 in CD4+T cells. Additionally, an
increased production of IL-10 by CD8+ T cells was observed, even though no
detectable changes in CD4+IL-10+ was noticed. Altogether, these results suggest
that the mechanism underlying the down-regulatory effects of BCG on OVA-induced
airway inflammation appear to be associated with the induction of both Th1 and T
regulatory immune responses.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
